Interviews

Interviews
FDA Approves Crizotinib for Pediatric ALK-Positive Anaplastic Large Cell Lymphoma
March 19, 2021
Yael Mossé, MD, discusses the recent approval of crizotinib for pediatrics patients and young adults with relapsed or refractory ALK-positive systemic ALCL.
Interviews
FDA Approves Crizotinib for Pediatric ALK-Positive Anaplastic Large Cell Lymphoma
March 19, 2021
Yael Mossé, MD, discusses the recent approval of crizotinib for pediatrics patients and young adults with relapsed or…
Interviews
MD Anderson, Philips Collaborate to Offer Personalized Care on a Global Scale
July 14, 2020
Kenna Shaw, PhD, and Louis Culot, discuss MD Anderson’s Precision Oncology Decision Support system and how the…
Interviews
Overcoming Resource, Reimbursement Barriers to Comprehensive Cancer Care Delivery
July 10, 2020
Al Bowen Benson III, MD, FACP, FASCO, discusses the depth of barriers to resource and reimbursement for comprehensive…
Interviews
Elsevier’s ClinicalPath: Supporting Value-Based Care and the Path Forward
JCP Editors, July 07, 2020
Members of the Elsevier ClinicalPath team discuss how pathways can assist institutions in reducing unwarranted…
Interviews
Huntsman at Home Program Provides Value Through Patient-Centered Care
JCP Editors, June 23, 2020
Kathi Mooney, PhD, RN, FAAN, interim senior director of population sciences, Huntsman Cancer Institute, shares the…
Interviews
Novel Ibrutinib Combination for Primary Treatment of CLL
JCP Editors, June 22, 2020
Neil Kay, MD, Mayo Clinic, comments on the data that led to a recent FDA expanded approval of ibrutinib and how it is…
Interviews
Identifying and Addressing Multi-Stakeholder Gaps in Value Assessment
JCP Editors, June 12, 2020
Jennifer Bright, MPA, and Lou Garrison, PhD, break down how value assessment and clinical pathways should evolve…
Interviews
Pharmacists to Gain Prescriber Status? The Changing Role of Pharmacists During COVID-19
JCP Editors, June 10, 2020
Sandra Leal, PharmD, MPH, FAPhA, CDCES, current president elect of the American Pharmacists Association, shares how…
Interviews
Prior Authorization for Comprehensive Genomic Profiling in Clinical Pathways
JCP Editors, May 27, 2020
Lee Schwartzberg, MD, FACP, West Cancer Center and Research Institute, examines the potential of genomic testing in…
Interviews
Providing Critical Clinical Trials to the Community: The ECHO Footprint
JCP Editors, May 14, 2020
Dinesh Kapur, MD, Eastern Connecticut Hematology and Oncology Associates, shares the unique identity the practice has…
Back to Top